THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net
S U M M A R Y
DIARY: March 9, 2004 12:52 PM Tuesday;
Rod Welch
Pathology report shows lumps are cancerous.
1...Summary/Objective
..............
Click here to comment!
CONTACTS
SUBJECTS
Cancer Cells Detected in Biopsy of Lumps in Neck Taken on 040303 by D
Laio, Been Doctor Called and Reported Cancer Cells Detected in Biopsy
Trial on New Cancer Treatment Double Blind Test Alternative Approach
0905 -
0905 - ..
0906 - Summary/Objective
0907 -
090701 - Follow up ref SDS 4 0000. ref SDS 3 0000.
090702 -
090703 - Millie called this afternoon. She reported that Doctor Laio just
090704 - called her and reported results of the biopsy on neck tissue from the
090705 - meeting at Kaiser on 040303, ref SDS 4 Y171, which was ordered by the
090706 - primary care physician on 040227 because lumps in the neck did not
090707 - respond to treatment, ref SDS 3 886G, after Millie complained of stiff
090708 - neck during the meeting on 040211. ref SDS 2 WP7L
090710 - ..
090711 - The pathology report shows cancerous cells were found.
090712 -
090713 - [On 040311 Millie's letter to her boss at Nixon Peabody, Gordon
090714 - Poole. ref SDS 5 LN95
090715 -
090716 - [On 040318 the doctor diagnoses metastatic cancer due to
090717 - recurrence. ref SDS 6 8R6M
090719 - ..
090720 - [On 040517 Millie diagnosed with inflammatory breast cancer,
090721 - ref SDS 7 7D6F, research indicates that swelled lymph nodes in
090722 - the neck above the collar bone are symptoms of IBC. ref SDS 7
090723 - M67I
090725 - ..
090726 - [On 041104 swelled lymph nodes in neck no longer identified by
090727 - CT testing, nor by clinical examination, after 9 months of
090728 - treatents. ref SDS 8 8R6M
090730 - ..
090731 - [On 051121 patient currently has no evidence of disease based
090732 - on estensive testing with biopsy, PET, CA 1503; prognosis is
090733 - for future relapse due to diagnosis of metastatic cancer, and
090734 - therefore mastectomy surgery on 051021 was palliation for
090735 - furture relapse. ref SDS 10 LH7M
090737 - ..
090738 - During a meeting on 040303 Doctor Laio advised that swelled lymph
090739 - nodes in the supraclavicular region of the neck will be removed by
090740 - surgery, whether or not diagnosed to be infected with cancer, and that
090741 - this operation would be performed within the next two (2) weeks.
090742 - ref SDS 4 Y193 Millie explained during the call today that Doctor
090743 - Laio related to her having discussed results of the biopsy with the
090744 - primary care physician in Oncology last Friday on 040305, and, for
090745 - some reason a decision was made not to perform surgery to remove even
090746 - lymph nodes in the neck found to be cancerous, which previously was
090747 - described as standard practice. Doctor Laio expects Millie will be
090748 - treated with chemotherapy again. This raises the question...
090749 -
090750 - Why not remove the cancerous lymph nodes in the neck with surgery,
090751 - as was done for the original tumor in the breast and the lymph
090752 - nodes under the arm on 020312? ref SDS 1 Q78M
090753 -
090754 - [On 040318 the doctor explains that Doctor Laio's findings of
090755 - cancer in lymph nodes show metastatic cancer which is more
090756 - conducive to treatment with chemotherapy, rather than with
090757 - surery. ref SDS 6 HC6K
090759 - ..
090760 - [On 040517 "minutes" of Tumor Board indicate radiation and
090761 - surgery to remove lymph nodes in the neck may be performed, if
090762 - chemotherapy is not successful. ref SDS 7 F77M
090764 - ..
090765 - [On 040517 Millie diagnosed with inflammatory breast cancer,
090766 - ref SDS 7 7D6F, research indicates that swelled lymph nodes in
090767 - the neck above the collar bone are symptoms of IBC. ref SDS 7
090768 - M67I
090770 - ..
090771 - [On 041104 swelled lymph nodes in neck no longer identified by
090772 - CT testing, nor by clinical examination, after 9 months of
090773 - treatment. ref SDS 8 8R6M
090775 - ..
090776 - [On 050826 referral surgeon in Kaiser's Oakland office
090777 - recommends removing additional lymph nodes in left auxillary,
090778 - which at the present time are not identified as cancerous; no
090779 - discussion of Doctor Laio's recommendation to remove swelled
090780 - lymph nodes in supraclavicular region. ref SDS 9 IZ8L
090781 -
090782 -
090784 - ..
0908 -
0909 -
0910 - 1713
0911 -
091101 - After work, Millie got a phone message at home from the primary care
091102 - physician in Oncology at Kaiser.
091104 - ..
091105 - The primary care physician has talked to Doctor Laio, and learned that
091106 - the biopsy on 040303, ref SDS 4 Y171, and which was ordered by the
091107 - primary care physician on 040227, ref SDS 3 886G, has now diagnosed
091108 - cancer relapse.
091110 - ..
091111 - The doctor further reported conversations with Rosalie, the Protocol
091112 - Nurse who manages clinical drug trials for treating cancer patients.
091113 - Good news, Millie qualifies to participate in a drug trial for Taxol
091114 - combined with a new chemotherapy agent called "Avastin." The doctor
091115 - said that strong results in trials using Avastin for colon cancer, and
091116 - favorable phase 1 trials for breast cancer, suggest referral to the
091117 - next phase of clinical trial is the best course of treatment for
091118 - Millie.
091120 - ..
091121 - The doctor wants to meet next week on 040318 to explain details of the
091122 - trial protocol.
091123 -
091124 - [On 040318 doctor proposes treatment with Avastin trial,
091125 - ref SDS 6 PU6M, introduces Protocol Nurse who explains details of
091126 - the trial. ref SDS 6 BK8M
091128 - ..
091129 - Millie has heard about the new treatment.
091131 - ..
091132 - Research on the Internet indicates clinical trials are underway
091133 - for bevacizumab (Avastin) and Taxol to treat breast cancer.
091134 - ref SDS 0 MT5U
091136 - ..
091137 - The primary care physician indicated in his message that the trial
091138 - would be a double blind protocol, so that Millie could be among the
091139 - 50% of participants who do not receive the trial treatment.
091140 -
091141 - Research indicates that Avastin is a complementary treatment to
091142 - normal chemotherapy. ref SDS 0 TQ33 So, there is not an issue
091143 - of getting no treatment. Millie will get the maximum treatment
091144 - she got previously, but if she happens to fall in the 50% of
091145 - the patients who get Avastin, rather than a placebo, then she
091146 - will get additional treatment.
091148 - ..
091149 - Additionally, comments from friends and family indicate that of
091150 - results of the tests are favorable, then the 50% of the placebo
091151 - patients are given the opportunity to receive the additional
091152 - treatment as well.
091154 - ..
091155 - Review on the Internet shows....
091156 -
091157 - http://www.gene.com/gene/products/information/oncology/avastin/
091158 -
091159 - Avastin is the first U.S. Food and Drug Administration (FDA)
091160 - approved therapy designed to inhibit angiogenesis, the process
091161 - by which new blood vessels develop and carry vital nutrients
091162 - to a tumor.
091164 - ..
091165 - Status
091167 - ..
091168 - The FDA approved Avastin in February 2004. Avastin is approved
091169 - for use in combination with intravenous 5-Fluorouracil-based
091170 - chemotherapy as a treatment for patients with first-line - or
091171 - previously untreated - metastatic cancer of the colon or
091172 - rectum.
091174 - ..
091175 - The Avastin FDA approval is based on data from a large,
091176 - placebo controlled, randomized study demonstrating
091177 - prolongation in the median survival of patients treated with
091178 - Avastin plus the IFL(5-FU/Leucovorin/CPT-11) chemotherapy
091179 - regimen by approximately five months, compared to patients
091180 - treated with the IFL chemotherapy regimen alone (20.3 months
091181 - versus 15.6 months). This is one of the largest improvements
091182 - in survival ever reported in a randomized, Phase III study of
091183 - patients with metastatic colorectal cancer
091185 - ..
091186 - Proposed Mechanism of Action
091188 - ..
091189 - Avastin is designed to inhibit Vascular Endothelial Growth
091190 - Factor (VEGF), a protein that plays an important role in tumor
091191 - angiogenesis and maintenance of existing tumor vessels. By
091192 - inhibiting VEGF, Avastin is designed to interfere with the
091193 - blood supply to tumors, a process that is critical to tumor
091194 - growth and metastasis
091196 - ..
091197 - Clinical Trials
091199 - ..
091200 - Based on preclinical and clinical studies showing that VEGF
091201 - plays a broad role in a range of cancers, Genentech is
091202 - pursuing a late-stage clinical development program with
091203 - Avastin evaluating its potential use in metastatic colorectal,
091204 - renal cell (kidney), breast and non-small cell lung cancers.
091205 - Avastin is also being evaluated in earlier stage trials as a
091206 - potential therapy in prostate, ovarian, melanoma and several
091207 - types of solid tumor cancers and hematologic malignancies.
091209 - ..
091210 - Application to breast cancer is confirmed by Genentech publications
091211 - per below. ref SDS 0 AX8L
091213 - ..
091214 - Genentech, the manufacturere, says...
091215 -
091216 - http://www.gene.com/gene/pipeline/status/oncology/avastin/index.jsp
091217 -
091218 - March 2004
091220 - ..
091221 - Description
091223 - ..
091224 - Avastin is a recombinant humanized antibody to Vascular
091225 - Endothelial Growth Factor (VEGF). Avastin is designed to bind
091226 - to and inhibit VEGF, a protein that plays a critical role in
091227 - tumor angiogenesis (the formation of new blood vessels to the
091228 - tumor).
091230 - ..
091231 - Development Status
091233 - ..
091234 - Genentech is pursuing a broad late-stage clinical development
091235 - program with Avastin, evaluating its potential use in multiple
091236 - tumor types. Phase III clinical trials in renal cell
091237 - carcinoma, advanced non-small cell lung cancer, and metastatic
091238 - breast cancer are being conducted. We are currently planning
091239 - for Phase III clinical trials in adjuvant colorectal cancer
091240 - and metastatic & locally advanced pancreatic cancer. This
091241 - product is being developed in collaboration with Hoffmann-La
091242 - Roche.
091244 - ..
091245 - Additional Information on Clinical Trials
091247 - ..
091248 - U.S. callers: 888-662-6728 Email:
091249 - genentechclinicaltrials@askatp.com
091251 - ..
091252 - National Institutes of Health Website
091253 - http://www.clinicaltrials.gov/
091255 - ..
091256 - For international inquiries, contact our international
091257 - partner, Roche, at +41-61-688-1111 or online at
091258 - http://www.roche.com/home.html
091259 -
091261 - ..
091262 - Forbes has an article...
091263 -
091264 - Pharmaceuticals
091265 - Genentech's Avastin Awaits FDA Approval
091266 - Matthew Herper, mherper@forbes.net
091267 - 09.29.03, 11:00 AM ET
091269 - ..
091270 - NEW YORK - Genentech has finished filing its application with
091271 - the U.S. Food and Drug Administration to sell Avastin as a
091272 - treatment for colorectal cancer. It is the first cancer drug
091273 - to work by starving the flow of blood to tumors, a process
091274 - called anti-angiogenesis.
091276 - ..
091277 - Avastin does this by inhibiting a protein called the vascular
091278 - endothelial growth factor. Avastin adds to the number of drugs
091279 - developed by directly targeting a specific protein; others
091280 - include Novartis' (nyse: NVS - news - people ) Gleevec,
091281 - AstraZeneca's (nyse: AZN - news - people ) Iressa and
091282 - Millennium's (nasdaq: MLNM - news - people ) Velcade. In May,
091283 - South San Francisco-based Genentech (nyse: DNA - news - people
091284 - ) said that Avastin extended survival in colon cancer
091285 - patients. Since then, the company's share price has almost
091286 - doubled.
091288 - ..
091289 - Genentech also announced that results from a second study of
091290 - Avastin in colon cancer are now expected in the fourth quarter
091291 - of 2003. Jason Kantor, an analyst at W.R. Hambrecht, says that
091292 - he suspects the FDA may want to see the data from this new
091293 - trial before it approves the drug. He also believes this
091294 - second trial will work out well. He owns shares of Genentech,
091295 - but his company does not do banking for the biotech. In
091296 - morning trading, shares of Genentech were off 39 cents to $80.
091297 -
091298 -
091300 - ..
091301 - US Food and Drug Administration says...
091302 -
091303 - http://www.fda.gov/cder/drug/infopage/avastin/avastinQ&A.htm
091304 -
091305 - Date created: February 26, 2004
091306 -
091307 - Questions and Answers on Avastin (bevacizumab)
091308 -
091309 - 1. What is Avastin (Bevacizumab), and how does it work?
091310 - ref SDS 0 HU9M
091312 - ..
091313 - 2. What are monoclonal antibodies?
091315 - ..
091316 - 3. What are angiogenesis inhibitors?
091318 - ..
091319 - 4. What is Avastin used to treat?
091321 - ..
091322 - 5. Is Avastin a cure for metastatic colorectal cancer?
091324 - ..
091325 - 6. How is Avastin given?
091327 - ..
091328 - 7. What are the possible side effects of Avastin?
091330 - ..
091331 - 8. Where can I find more information on Avastin and colorectal
091332 - cancer?
091333 -
091334 -
091336 - ..
091337 - 1. What is Avastin (bevacizumab), and how does it work?
091338 -
091339 - Avastin is a monoclonal antibody that works by attaching to
091340 - and inhibiting the action of vascular endothelial growth factor
091341 - (VEGF) in laboratory experiments. VEGF is a substance that
091342 - binds to certain cells to stimulate new blood vessel formation.
091343 - When VEGF is bound to Avastin, it cannot stimulate the
091344 - formation and growth of new blood vessels (angiogenesis).
091345 - Avastin enhances the effects of chemotherapy, but does not
091346 - appear to be effective when given alone in patients with
091347 - colorectal cancer.
091349 - ..
091350 - 2. What are monoclonal antibodies?
091351 -
091352 - Antibodies are substances produced by the immune system in
091353 - response to foreign substances such as bacteria, viruses or
091354 - toxins). They are the body's natural defense mechanism
091355 - against infection, as they help to destroy these foreign
091356 - substances. Monoclonal antibodies are antibodies produced in a
091357 - laboratory to target a very specific part of the foreign
091358 - substance (antigen). Because of their precision, it is
091359 - expected that they may be more effective than standard
091360 - chemotherapy with fewer side effects.
091362 - ..
091363 - 3. What are angiogenesis inhibitors?
091364 -
091365 - Angiogenesis inhibitors prevent the formation of new blood
091366 - vessels, including those that surround and supply cancer
091367 - cells, with the oxygen and nutrients they need to survive and
091368 - grow. By taking away the blood supply, angiogenesis
091369 - inhibitors may reduce tumor cell growth and cause cancerous
091370 - tumors to grow more slowly or to become smaller.
091372 - ..
091373 - 4. What is Avastin used to treat?
091374 -
091375 - Avastin is used to treat cancer of the colon or rectum that
091376 - has spread to other parts of the body. Avastin is given along
091377 - with the chemotherapy combination known as IFL. IFL consists
091378 - of irinotecan, 5-fluorouracil (5-FU), and leucovorin
091380 - ..
091381 - 5. Is Avastin a cure for metastatic colorectal cancer?
091382 -
091383 - No, Avastin will not cure metastatic colorectal cancer. In
091384 - clinical trials there was longer survival and tumor control in
091385 - patients who received the combination of IFL plus Avastin than
091386 - among those who received IFL without Avastin. Overall,
091387 - patients given Avastin survived about five months longer. In
091388 - addition, the average time before tumors restarted growing or
091389 - new tumors appeared was four months longer than patients who
091390 - did not receive Avastin
091391 -
091393 - ..
091394 - 6. How is Avastin given?
091395 -
091396 - Avastin is given intravenously (into a vein) every 14 days.
091398 - ..
091399 - 7. What are the possible side effects of Avastin?
091400 -
091401 - Serious side effects include:
091402 -
091403 - holes in the colon requiring surgery to repair
091404 - (gastrointestinal perforation)
091406 - ..
091407 - impaired wound healing
091409 - ..
091410 - bleeding leading to disability (stroke) or death
091411 - (especially in lung cancer patients)
091413 - ..
091414 - heart failure in certain patients (those given or
091415 - receiving other anti-cancer treatments that may injure the
091416 - heart muscle) kidney damage
091417 -
091419 - ..
091420 - Other more common side effects of Avastin treatment are:
091421 -
091422 - high blood pressure
091423 -
091424 - tiredness/weakness
091425 -
091426 - clot in the vein (thrombophlebitis)
091428 - ..
091429 - diarrhea
091431 - ..
091432 - decreased white blood cells
091434 - ..
091435 - headache
091437 - ..
091438 - loss of appetite
091440 - ..
091441 - mouth sores
091442 -
091443 -
091444 -
091445 -
091446 -
091447 -
091448 -
091449 -
091450 -
091451 -
091452 -
091453 -
091454 -
091455 -
091456 -
091457 -
091458 -
0915 -